Patent · US Active

Dissymmetric N,N-dialkylamides used particularly for separating uranium(VI) from plutonium(IV), synthesis thereof and uses of same

US11578031B2 · kind B2 · utility

0Cited by
2References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 25, 2018
Grant dateFeb 14, 2023
Priority date
Expiry dateSep 30, 2039

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02W30/50
  • WIPO fieldMaterials, metallurgy
  • WIPO sectorChemistry

Abstract

A dissymmetric RN,N-dialkylamides of formula (I) in which: R1 represents a linear C1 to C4 alkyl, R2 represents a linear C1 to C10 alkyl, and R3 represents a linear or branched C6 to C15 alkyl, where R3 is different from a n-octyl, n-decyl, n-dodecyl, 2-ethylhexyl and 2-ethyloctyl group when R1 represents a n-butyl group and R2 represents an ethyl group. A method for synthesising the N,N-dialkylamides, and uses of same for extracting uranium and/or plutonium from an aqueous acid solution or for fully or partially separating the uranium from the plutonium contained in an aqueous acid solution and a solution resulting from the dissolution of spent nuclear fuel in nitric acid. A method for treating an aqueous solution resulting from the dissolution of spent nuclear fuel in nitric acid, which allows the uranium and the plutonium contained in the solution to be extracted, separated and decontaminated in a single cycle.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.